Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lung Neoplasms × Data Collection × Clear all

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 13 Pancreatic Neoplasms 5 Breast Neoplasms 5 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Uterine Cervical Neoplasms 2 Thyroid Diseases 2 Prostatic Neoplasms 2 Pancreatic Cyst 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Wilms Tumor 1 Venous Thrombosis 1 Venous Thromboembolism 1 Uveal Melanoma 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thrombosis 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Carboplatin 141 Radiotherapy 119 Cisplatin 92 Pemetrexed 88 Docetaxel 77 Paclitaxel 76 Gemcitabine 67 Magnetic Resonance Spectroscopy 64 Erlotinib Hydrochloride 58 Radiosurgery 56 pembrolizumab 54 Bevacizumab 53 Etoposide 48 durvalumab 43 Blood Specimen Collection 40 Specimen Handling 39 Nivolumab 39 Surveys and Questionnaires 36 Drug Therapy 30 osimertinib 28 Topotecan 28 Standard of Care 28 atezolizumab 27 Radiation 26 Surgical Procedures, Operative 25 Vinorelbine 24 Educational Status 24 Early Intervention, Educational 23 Biopsy 23 Methods 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05783024 2023-05-10

ADAMpartlung

AZ Delta

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡